<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Clin Case Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Clin Case Rep</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2050-0904</journal-id>
<journal-id journal-id-type="publisher-id">CCR3</journal-id>
<journal-title-group>
<journal-title>Clinical Case Reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2050-0904</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29445472</article-id>
<article-id pub-id-type="pmc">5799615</article-id>
<article-id pub-id-type="doi">10.1002/ccr3.1361</article-id>
<article-id pub-id-type="publisher-id">CCR31361</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Case Report</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Case Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mild prominence of the Sylvian fissure in a Bainbridge‐Ropers syndrome patient with a novel frameshift variant in <italic><styled-content style="fixed-case">ASXL</styled-content>3</italic>
</article-title>
<alt-title alt-title-type="left-running-head">Y. Chinen <italic>et al</italic>.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" id="ccr31361-cr-0001">
<name>
<surname>Chinen</surname>
<given-names>Yasutsugu</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9486-6336</contrib-id>
<address>
<email>ychinen@med.u-ryukyu.ac.jp</email>
</address>
<xref ref-type="aff" rid="ccr31361-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="ccr31361-cr-0002">
<name>
<surname>Nakamura</surname>
<given-names>Sadao</given-names>
</name>
<xref ref-type="aff" rid="ccr31361-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="ccr31361-cr-0003">
<name>
<surname>Ganaha</surname>
<given-names>Akira</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2800-8886</contrib-id>
<xref ref-type="aff" rid="ccr31361-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="ccr31361-cr-0004">
<name>
<surname>Hayashi</surname>
<given-names>Shin</given-names>
</name>
<xref ref-type="aff" rid="ccr31361-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="ccr31361-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="ccr31361-cr-0005">
<name>
<surname>Inazawa</surname>
<given-names>Johji</given-names>
</name>
<xref ref-type="aff" rid="ccr31361-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="ccr31361-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="ccr31361-cr-0006">
<name>
<surname>Yanagi</surname>
<given-names>Kumiko</given-names>
</name>
<xref ref-type="aff" rid="ccr31361-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="ccr31361-cr-0007">
<name>
<surname>Nakanishi</surname>
<given-names>Koichi</given-names>
</name>
<xref ref-type="aff" rid="ccr31361-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="ccr31361-cr-0008">
<name>
<surname>Kaname</surname>
<given-names>Tadashi</given-names>
</name>
<xref ref-type="aff" rid="ccr31361-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="ccr31361-cr-0009">
<name>
<surname>Naritomi</surname>
<given-names>Kenji</given-names>
</name>
<xref ref-type="aff" rid="ccr31361-aff-0006">
<sup>6</sup>
</xref>
</contrib>
</contrib-group>
<aff id="ccr31361-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Pediatrics</named-content>
<named-content content-type="organisation-division">Faculty of Medicine</named-content>
<institution>University of the Ryukyus</institution>
<named-content content-type="city">Nishihara</named-content>
<country country="JP">Japan</country>
</aff>
<aff id="ccr31361-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Otorhinolaryngology, Head and Neck Surgery</named-content>
<named-content content-type="organisation-division">Faculty of Medicine</named-content>
<institution>University of the Ryukyus</institution>
<named-content content-type="city">Nishihara</named-content>
<country country="JP">Japan</country>
</aff>
<aff id="ccr31361-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Molecular Cytogenetics</named-content>
<named-content content-type="organisation-division">Medical Research Institute</named-content>
<institution>Tokyo Medical and Dental University</institution>
<named-content content-type="city">Tokyo</named-content>
<country country="JP">Japan</country>
</aff>
<aff id="ccr31361-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Hard Tissue Genome Research Center</named-content>
<institution>Tokyo Medical and Dental University</institution>
<named-content content-type="city">Tokyo</named-content>
<country country="JP">Japan</country>
</aff>
<aff id="ccr31361-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Department of Genome Medicine</named-content>
<institution>National Center for Child Health and Development</institution>
<named-content content-type="city">Tokyo</named-content>
<country country="JP">Japan</country>
</aff>
<aff id="ccr31361-aff-0006">
<label><sup>6</sup></label>
<institution>Okinawa Nanbu Habilitation and Medical Center</institution>
<named-content content-type="city">Naha</named-content>
<country country="JP">Japan</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Yasutsugu Chinen, Department of Pediatrics, Faculty of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa 903‐0125, Japan. Tel: +81 098 895 3331; Fax: +81 098 895 1418; E‐mail: <email>ychinen@med.u-ryukyu.ac.jp</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>2</month>
<year>2018</year>
</pub-date>
<volume>6</volume>
<issue>2</issue>
<issue-id pub-id-type="doi">10.1002/ccr3.2018.6.issue-2</issue-id>
<fpage>330</fpage>
<lpage>336</lpage>
<history>
<date date-type="received">
<day>01</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>27</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>12</month>
<year>2017</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 John Wiley & Sons Ltd. <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2017 The Authors. <italic>Clinical Case Reports</italic> published by John Wiley &amp; Sons Ltd.</copyright-statement>
<license license-type="creativeCommonsBy-nc-nd">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution‐NonCommercial‐NoDerivs</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:CCR3-6-330.pdf" xlink:type="simple"></self-uri>
<abstract id="ccr31361-abs-0001">
<title>Key Clinical Message</title>
<p>A Japanese boy aged 7 years with Bainbridge‐Ropers syndrome (<styled-content style="fixed-case">BRPS</styled-content>) had a prominent domed forehead without metric ridge, mild prominence of the Sylvian fissure with bitemporal hollowing, and a heterozygous de novo novel variant “p.P1010Lfs*14” in <italic><styled-content style="fixed-case">ASXL</styled-content>3</italic> gene in addition to typical findings of <styled-content style="fixed-case">BRPS</styled-content>.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="ccr31361-kwd-0001">
<italic><styled-content style="fixed-case">ASXL</styled-content>3</italic>
</kwd>
<kwd id="ccr31361-kwd-0002">Bainbridge‐Ropers syndrome</kwd>
<kwd id="ccr31361-kwd-0003">Sylvian fissure</kwd>
</kwd-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="1"></table-count>
<page-count count="7"></page-count>
<word-count count="3336"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>ccr31361</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>February 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.3.2.2 mode:remove_FC converted:19.02.2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="ccr31361-cit-1001" publication-type="journal">
<source/>Clinical Case Reports
<year>2018</year>; <volume>6</volume>(<issue>2</issue>): <fpage>330</fpage>–<lpage>336</lpage>
<pub-id pub-id-type="pmid">29445472</pub-id></mixed-citation>
</p>
</notes>
</front>
<body>
<sec id="ccr31361-sec-0001">
<title>Introduction</title>
<p>Bainbridge<bold>–</bold>Ropers syndrome (BRPS; MIM 615485) was first described in 2013 and is characterized by failure to thrive, feeding problems, severe developmental delay, hypotonia, autism, delays in language acquisition, postnatal growth retardation, and abnormal facial features with arched eyebrows and anteverted nares. BRPS is caused by de novo dominant truncating variants in the Transcriptional Regulator gene Additional Sex Combs Like 3 (<italic>ASXL3</italic>), while missense variants in <italic>ASXL3</italic> have been identified in individuals with autism spectrum disorder (ASD) <xref ref-type="ref" rid="ccr31361-bib-0001">1</xref>, <xref ref-type="ref" rid="ccr31361-bib-0003">3</xref>, <xref ref-type="ref" rid="ccr31361-bib-0005">5</xref>, <xref ref-type="ref" rid="ccr31361-bib-0014">14</xref>. ASXL family members are assumed to be epigenetic regulators that are involved in hereditary neurological disorders as well as malignancies <xref ref-type="ref" rid="ccr31361-bib-0001">1</xref>, <xref ref-type="ref" rid="ccr31361-bib-0002">2</xref>, <xref ref-type="ref" rid="ccr31361-bib-0006">6</xref>, <xref ref-type="ref" rid="ccr31361-bib-0008">8</xref>.</p>
<p>We describe a boy aged 7 years with a novel frameshift variant in <italic>ASXL3</italic>, identified by whole‐exome and Sanger sequencing. The patient had characteristic BRPS features as well as additional findings of mild prominence of the Sylvian fissure with bitemporal hollowing, stereotypic movements such as whispering face and hand‐wringing, deep palmar creases, abnormal facial features, and severe developmental delay with speech delay with only a few meaningful words.</p>
</sec>
<sec id="ccr31361-sec-0002">
<title>Clinical Report</title>
<p>The patient was a boy, the first born child to a healthy, nonconsanguineous couple. At the time of his birth, both of parents were 35 years of age. Two other elder children were healthy. There was no family history of BRPS. Both of pregnancy and delivery at 39 weeks of gestation were uneventful. At birth, weight was 3658 g (+1.6 SD), length 47.4 cm (−0.7 SD), and occipitofrontal circumference (OFC) 37.5 cm (+2.8 SD). Hearing impairment was suspected in audiometry of the newborn screening at the age of 5 days. In addition to that, he was referred to our clinic for failure to thrive. At the age of 1 month, his weight was 4380 g (−1.6 SD), length 54.8 cm (−1.2 SD), and OFC 38.0 cm (−0.5 SD). He had a prominent forehead, arched eyebrows, edematous periorbital region, hypertelorism, short nose, anteverted nostrils, long philtrum, thin upper lip, full cheeks, bitemporal hollowing, and deep palmar creases without camptodactyly (Fig. <xref ref-type="fig" rid="ccr31361-fig-0001">1</xref>A,C,H,I). He had mild hypotonia and bilateral mild sensorineural deafness (40–50 dB). Ophthalmological findings showed hyperopia and astigmatism. He had been repeatedly admitted to hospital for asthmatic bronchitis up to the age of 4 years. His developmental milestones were delayed – head control at the age of 6 months, rollover at 8 months, sitting unaided at 2 years and 4 months, walking with support at 2 years and 7 months. At the age of 7 years, he had a few meaningful words. He had stereotypic movements such as whispering face (Fig. <xref ref-type="fig" rid="ccr31361-fig-0001">1</xref>B) and hand‐wringing. At the age of 4 years, his length was 88.0 cm (−3.0 SD), weight 11.5 kg (−2.1 SD), and OFC 48.5 cm (−1.1 SD). At the age of 7 years and 10 months, he was evaluated to have profound mental retardation (DQ = 10) and short stature (105.0 cm; −3.7 SD) as well as poor weight gain (16.2 kg; −1.9 SD). Auditory brain stem response (ABR) revealed normal hearing ability at age 7 years. Radiological examination at the age of 3 years revealed scoliosis at Th12‐L1 (Fig. <xref ref-type="fig" rid="ccr31361-fig-0002">2</xref>L). Magnetic resonance imaging (MRI) showed a hypoplastic body of the corpus callosum (Fig. <xref ref-type="fig" rid="ccr31361-fig-0002">2</xref>A), mild bilateral prominence of the Sylvian fissure (Fig. <xref ref-type="fig" rid="ccr31361-fig-0002">2</xref>B–D,F–H), mild atrophy of the cerebellar vermis (Fig. <xref ref-type="fig" rid="ccr31361-fig-0002">2</xref>E), and mild white matter loss of the left frontal lobe with normal myelination (Fig. <xref ref-type="fig" rid="ccr31361-fig-0002">2</xref>D,H). The intrafissural venous plexus of the right parietal area (Fig. <xref ref-type="fig" rid="ccr31361-fig-0002">2</xref>I) was reduced at the age of 3 years and 7 months compared with the finding at 9 months. No malformation of the carotid artery was detected by magnetic resonance angiography. Three‐dimensional CT imaging showed prominent domed forehead without the ridge of the metopic suture and also shallow hollowing of the backward region of the frontoparietal suture without craniosynostosis (Fig. <xref ref-type="fig" rid="ccr31361-fig-0002">2</xref>J,K), consistent with the region where mild prominence of the Sylvian fissure was found. Levels of plasma amino acids, urinary organic acids, lactate and pyruvic acid, and blood gas analysis were all normal. A chromosomal analysis showed a normal karyotype. We searched the original computerized database for possible malformation syndromes: UR‐DBMS (University of the Ryukyus‐Database for Malformation Syndromes: <ext-link ext-link-type="uri" xlink:href="http://becomerich.lab.u-ryukyu.ac.jp">http://becomerich.lab.u-ryukyu.ac.jp</ext-link>) edited by Naritomi <xref ref-type="ref" rid="ccr31361-bib-0012">12</xref>. Although Char syndrome (MIM 169100), Miller–Dieker lissencephaly syndrome (MIM 247200), Pallister–Killian syndrome (MIM 601803), 10q26 deletion, 2q3 trisomy, 7q3 monosomy were suggested as candidates matching all nine signs, no syndromes were considered to be appropriate. An array‐based comparative genomic hybridization analysis revealed no pathogenic copy number variations in the patient. Whole‐exome sequencing using the SureSelect Human All Exon V6 kit (Agilent Technologies, Santa Clara, CA) and HiSeq2500 (illumina, San Diego, CA) was performed. To identify disease‐causative mutations, we excluded all known variants found in the 1000 Genomes database (<ext-link ext-link-type="uri" xlink:href="http://www.internationalgenome.org/">http://www.internationalgenome.org/</ext-link>), Japanese Genomes database <xref ref-type="ref" rid="ccr31361-bib-0011">11</xref>, dbSNP (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.gov/SNP">http://www.ncbi.nlm.gov/SNP</ext-link>), the genome Aggregation Database (gnomAD; <ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org/">http://gnomad.broadinstitute.org/</ext-link>), and the Human Genetic Variation Database (HGVD; <ext-link ext-link-type="uri" xlink:href="http://www.genome.med.kyoto-u.ac.jp/SnpDB/">http://www.genome.med.kyoto-u.ac.jp/SnpDB/</ext-link>). By focusing on nonsynonymous SNVs, insertions and deletions, and splice site variants, we narrowed down to 10 variants including four autosomal dominant inherited types and six autosomal recessive inherited types (Table <xref ref-type="supplementary-material" rid="ccr31361-sup-0001">S1</xref>). A heterozygous mutation in the <italic>ASXL3</italic> gene (<ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_030632">NM_030632</ext-link>) is causative for BRPS, which was considered highly similar to our patient. We identified a heterozygous single nucleotide deletion (c.3028delC) in exon 11 of <italic>ASXL3</italic> gene, which resulted in a frameshift (p.P1010L<italic>fs</italic>*14) and a truncated protein. The p.P1010L<italic>fs</italic>*14 variant was not detected in his parents, suggesting that the variant was de novo. This finding was confirmed by Sanger sequencing (Fig. <xref ref-type="fig" rid="ccr31361-fig-0003">3</xref>). The p.P1010L<italic>fs</italic>*14 variant was not previously described and predicted by Mutation Taster (<ext-link ext-link-type="uri" xlink:href="http://www.mutationtaster.org">http://www.mutationtaster.org</ext-link>) as a disease‐causing variant.</p>
<fig fig-type="Figure" id="ccr31361-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Patient's appearance: at age 1 year and 2 months (A–C) and 7 years and 6 months (D–I). Face (front; A, B, E, lateral; C, F), full‐length body (D), head (G), hand (left; H, right; I). Reproduction of the pictures was kindly permitted by his parents.</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="CCR3-6-330-g001"></graphic>
</fig>
<fig fig-type="Figure" id="ccr31361-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<p>Imaging study taken at the age of 9 months (A–D, I), 2 years and 7 months (E–H), 3 years and 7 months (J, K), and 7 years and 5 months (L). T1 <styled-content style="fixed-case">MRI</styled-content> imaging of the brain; sagittal plane: median (A), left side (B, F), and cross section (C–E, G, H). Cross‐sectional <styled-content style="fixed-case">SW</styled-content>1 <styled-content style="fixed-case">MRI</styled-content> imaging (I). Frontal view of the brain by three‐dimensional <styled-content style="fixed-case">CT</styled-content> imaging (J, K) and of the spine by radiography (L). <styled-content style="fixed-case">MRI</styled-content>, magnetic resonance imaging; <styled-content style="fixed-case">CT</styled-content>, computerized tomography.</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="CCR3-6-330-g002"></graphic>
</fig>
<fig fig-type="Figure" id="ccr31361-fig-0003" orientation="portrait" position="float" xml:lang="en">
<label>Figure 3</label>
<caption>
<p>Sequencing profiles of the <italic><styled-content style="fixed-case">ASXL</styled-content>3</italic> gene in the patient and his parents. Integrative genomics viewer images of next‐generation sequencing data of the <styled-content style="fixed-case">ASXL</styled-content>3 gene at exon 13 and Sanger sequencing diagram for the patient (III‐1), father (II‐5), and mother (II‐10). An arrow indicates the deletion of cytosine nucleotide.</p>
</caption>
<graphic id="nlm-graphic-7" xlink:href="CCR3-6-330-g003"></graphic>
</fig>
<p>The study was performed in accordance with the standards of the Ethics Committee of the Ryukyus Graduate School of Medicine (Okinawa, Japan). Informed consent for his parents was obtained by Dr. Yasutsugu Chinen.</p>
</sec>
<sec id="ccr31361-sec-0003">
<title>Discussion</title>
<p>BRPS is a unique disorder that has phenotypic overlap with Bohring–Opitz syndrome (BOS) (also known as C‐like syndrome: MIM 605039), which is caused by heterozygous variant in the <italic>ASXL1</italic> gene (MIM 612990) on chromosome 20q11, Shashi‐Pena syndrome (SHAPNS) (MIM 617190), which is caused by heterozygous variant in the <italic>ASXL2</italic> gene (MIM 612991) on chromosome 2p23, and C syndrome (Opitz trigonocephaly syndrome: MIM 211750), which is caused by heterozygous variant in the <italic>CD96</italic> gene on chromosome 3q13 <xref ref-type="ref" rid="ccr31361-bib-0001">1</xref>, <xref ref-type="ref" rid="ccr31361-bib-0005">5</xref>, <xref ref-type="ref" rid="ccr31361-bib-0007">7</xref>, <xref ref-type="ref" rid="ccr31361-bib-0014">14</xref>. The features of C syndrome are, however, milder than those of BOS.</p>
<p>Unlike BOS, SHAPNS, and C syndrome, in BRPS, trigonocephaly, prominent metopic suture, exophthalmos, nevus flammeus of the face, upslanting palpebral fissures, redundant skin, hirsutism, and “BOS posture” of elbow and wrist flexion are mild or absent <xref ref-type="ref" rid="ccr31361-bib-0001">1</xref>, <xref ref-type="ref" rid="ccr31361-bib-0005">5</xref>, <xref ref-type="ref" rid="ccr31361-bib-0007">7</xref>, <xref ref-type="ref" rid="ccr31361-bib-0014">14</xref>. The phenotype of the propositus is concordant with those of previous reports of BRPS – severe/profound mental retardation, hypotonia, delays in language acquisition, short stature of postnatal onset, craniofacial dysmorphism (prominent forehead, arched eyebrows, edematous periorbital region, short nose, anteverted nostrils, long philtrum, thin upper lip, full cheeks), and central nervous system abnormalities (hypoplastic body of the corpus callosum, mild atrophy of the cerebellar vermis, mild white matter loss of the frontal lobe). Prominent domed forehead with bitemporal hollowing and without metopic ridge might be one of the hallmarks in BRPS. Unlike previous reports, the patient had additional findings, that is, stereotypic movements (whispering face and hand‐wringing), deep palmar creases, mild prominence of the Sylvian fissure with bitemporal hollowing, intrafissural venous plexus in the right parietal area, and scoliosis. Deep palmar creases were reported in SHAPNS by Shashi et al. <xref ref-type="ref" rid="ccr31361-bib-0014">14</xref>. Our listed variations other than the <italic>ASXL3</italic> gene and the <italic>DISC1</italic> gene (Table <xref ref-type="supplementary-material" rid="ccr31361-sup-0001">S1</xref>) had not yet been established gene–phenotype relationships. DISC1 may confer susceptibility to psychiatric illnesses such as schizophrenia, schizoaffective disorder, and bipolar disorder <xref ref-type="ref" rid="ccr31361-bib-0010">10</xref>, <xref ref-type="ref" rid="ccr31361-bib-0013">13</xref>, <xref ref-type="ref" rid="ccr31361-bib-0015">15</xref>. We should consider whether a degree of clinical findings might be affected by those variations with unestablished gene–phenotype relationships, but we could not disclose such an influence in the present study.</p>
<p>In previous reports of BRPS, all of the disease‐causing variants in <italic>ASXL3</italic> were truncating variants, mostly located in the first half of exon 11. Similarly, a novel de novo frameshift variant, p.P1010L<italic>fs</italic>*14, found in the present patient also located in <italic>ASXL3</italic> exon 11. Pathogenic missense variants in <italic>ASXL3</italic> have not been identified in patients with BRPS; however, such variants have been reported in ASD cases <xref ref-type="ref" rid="ccr31361-bib-0003">3</xref>. The clinical phenotype of ASD individuals with missense variants in <italic>ASXL3</italic> has not been clearly identified by brain imaging. Brain MRI assessments of BRPS patients (including the present patient and those from previous reports) show mild white matter volume loss in 50% (6/12), mild corpus callosum hypoplasia in 42% (5/12), and mild cerebellar vermis hypoplasia in 42% (5/12) of patients (Table <xref ref-type="table-wrap" rid="ccr31361-tbl-0001">1</xref>) . Secondary findings affected by white matter volume loss might be mild enlargement of lateral ventricles and mild prominence of the sulci. The present patient had autistic features, including whispering face and hand‐wringing and the ability to say only a few meaningful words. Differences in cortical thickness were observed between individuals with ASD and controls at the bilateral inferior frontal gyrus, pars opercularis, pars triangularis, the right caudal middle frontal and left rostral middle frontal regions, and the left frontal pole <xref ref-type="ref" rid="ccr31361-bib-0017">17</xref>. Mild prominence of the Sylvian fissure might be affected by white matter volume loss or reduced cortical thickness at the bilateral inferior frontal gyrus, pars opercularis, and pars triangularis. Further brain imaging characteristics in patients with BRPS might be useful for assessing ASD individuals with missense variants in <italic>ASXL3</italic>.</p>
<table-wrap id="ccr31361-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Brain MRI assessments of BRPS patients from this study and previous reports</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Patients with BRPS</td>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="left" colspan="1" rowspan="1">B</td>
<td align="left" colspan="2" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">D</td>
<td align="left" colspan="6" rowspan="1">E</td>
<td align="left" colspan="1" rowspan="1">F</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Number of patients assessed by brain MRI/total number</td>
<td align="left" colspan="1" rowspan="1">1/4</td>
<td align="left" colspan="1" rowspan="1">1/1</td>
<td align="left" colspan="2" rowspan="1">2/3</td>
<td align="left" colspan="1" rowspan="1">1/1</td>
<td align="left" colspan="6" rowspan="1">6/6</td>
<td align="left" colspan="1" rowspan="1">1/1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mild white matter volume loss</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mild prominence of the sulci</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mild enlargement of lateral ventricles</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mild brain stem hypoplasia</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mild corpus callosum hypoplasia</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hypoplasia/dysplasia of bilateral cerebellar tonsils</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mild cerebellar vermal hypoplasia</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="ccr31361-note-0002">
<p>References: A <xref ref-type="ref" rid="ccr31361-bib-0001">1</xref>; B <xref ref-type="ref" rid="ccr31361-bib-0004">4</xref>; C <xref ref-type="ref" rid="ccr31361-bib-0016">16</xref>; D <xref ref-type="ref" rid="ccr31361-bib-0005">5</xref>; E <xref ref-type="ref" rid="ccr31361-bib-0009">9</xref>; F, the present case; +, present; −, absent/normal.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="ccr31361-sec-0005">
<title>Authorship</title>
<p>YC: was the principal investigator of this article and contributed to the conception, analysis of data, and reporting of the work described in the article. He performed patient follow‐up. SN: contributed to clinical management and neurological assessment. AK: contributed to estimate hearing ability and data analysis. SH: contributed to an array‐based comparative genomic hybridization analysis. JI: contributed to an array‐based comparative genomic hybridization analysis. KY: contributed to DNA analysis of whole‐exome sequencing and data analysis. KN: contributed to data analysis and reporting of the work described in the article. TK: contributed to the planning, data analysis, and reporting of the work described in the article. KN: contributed to data analysis and reporting of the work described in the article.</p>
</sec>
<sec id="ccr31361-sec-0006">
<title>Conflict of Interest</title>
<p>None declared.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="ccr31361-sup-0001">
<caption>
<p>
<bold>Table S1</bold>. Gene variations with phenotype‐causing potentiality.</p>
</caption>
<media xlink:href="CCR3-6-330-s001.xlsx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="ccr31361-sec-0004">
<title>Acknowledgments</title>
<p>We thank Takaya Tohma, Yoko Ohashi, Naoko Ohata, Tomoko Makiya, Yukiko Chinen, Takashi Matsuoka, Kaoru Yamashita, and Jun Touyama of the committee for clinical malformation diagnosis in Okinawa for the Initiative of Rare and Undiagnosed Diseases in Pediatrics (IRUD‐P) project in Japan. We are indebted to the participants, their parents, nurses, and pediatricians who supported this study. The authors would like to thank the Genome Aggregation Database (gnomAD) and the groups that provided exome and genome variant data to this resource.</p>
</ack>
<ref-list content-type="cited-references" id="ccr31361-bibl-0001">
<title>References</title>
<ref id="ccr31361-bib-0001">
<label>1</label>
<mixed-citation id="ccr31361-cit-0001" publication-type="journal">
<string-name>
<surname>Bainbridge</surname>, <given-names>M. N.</given-names>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Hu</surname>
</string-name>, <string-name>
<given-names>D. M.</given-names>
<surname>Muzny</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Musante</surname>
</string-name>, <string-name>
<given-names>J. R.</given-names>
<surname>Lupski</surname>
</string-name>, <string-name>
<given-names>B. H.</given-names>
<surname>Graham</surname>
</string-name>, et al. <year>2013</year>
<article-title>De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring‐Opitz syndrome</article-title>. <source/>Genome Med.
<volume>5</volume>:<fpage>11</fpage>.<pub-id pub-id-type="pmid">23383720</pub-id></mixed-citation>
</ref>
<ref id="ccr31361-bib-0002">
<label>2</label>
<mixed-citation id="ccr31361-cit-0002" publication-type="journal">
<string-name>
<surname>Balasubramanian</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Willoughby</surname>
</string-name>, <string-name>
<given-names>A. E.</given-names>
<surname>Fry</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Weber</surname>
</string-name>, <string-name>
<given-names>H. V.</given-names>
<surname>Firth</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Deshpande</surname>
</string-name>, et al. <year>2017</year>
<article-title>Delineating the phenotypic spectrum of Bainbridge‐Ropers syndrome: 12 new patients with <italic>de novo</italic>, heterozygous, loss‐of‐function mutations in <italic>ASXL3</italic> and review of published literature</article-title>. <source/>J. Med. Genet.
<volume>54</volume>:<fpage>537</fpage>–<lpage>543</lpage>.<pub-id pub-id-type="pmid">28100473</pub-id></mixed-citation>
</ref>
<ref id="ccr31361-bib-0003">
<label>3</label>
<mixed-citation id="ccr31361-cit-0003" publication-type="journal">
<string-name>
<surname>De Rubeis</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>He</surname>
</string-name>, <string-name>
<given-names>A. P.</given-names>
<surname>Goldberg</surname>
</string-name>, <string-name>
<given-names>C. S.</given-names>
<surname>Poultney</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Samocha</surname>
</string-name>, <string-name>
<given-names>A. E.</given-names>
<surname>Cicek</surname>
</string-name>, et al. <year>2014</year>
<article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>. <source/>Nature
<volume>515</volume>(<issue>7526</issue>):<fpage>209</fpage>–<lpage>215</lpage>.<pub-id pub-id-type="pmid">25363760</pub-id></mixed-citation>
</ref>
<ref id="ccr31361-bib-0004">
<label>4</label>
<mixed-citation id="ccr31361-cit-0004" publication-type="journal">
<string-name>
<surname>Dinwiddie</surname>, <given-names>D. L.</given-names>
</string-name>, <string-name>
<given-names>S. E.</given-names>
<surname>Soden</surname>
</string-name>, <string-name>
<given-names>C. J.</given-names>
<surname>Saunders</surname>
</string-name>, <string-name>
<given-names>N. A.</given-names>
<surname>Miller</surname>
</string-name>, <string-name>
<given-names>E. G.</given-names>
<surname>Farrow</surname>
</string-name>, <string-name>
<given-names>L. D.</given-names>
<surname>Smith</surname>
</string-name>, et al. <year>2013</year>
<article-title>De novo frameshift mutation in ASXL3 in a patient with global developmental delay, microcephaly, and craniofacial anomalies</article-title>. <source/>BMC Med. Genomics
<volume>6</volume>:<fpage>32</fpage>.<pub-id pub-id-type="pmid">24044690</pub-id></mixed-citation>
</ref>
<ref id="ccr31361-bib-0005">
<label>5</label>
<mixed-citation id="ccr31361-cit-0005" publication-type="journal">
<string-name>
<surname>Hori</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Miya</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Ohashi</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Negishi</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Hattori</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Ando</surname>
</string-name>, et al. <year>2016</year>
<article-title>Novel splicing mutation in the ASXL3 gene causing Bainbridge‐Ropers syndrome</article-title>. <source/>Am. J. Med. Genet. A
<volume>170</volume>:<fpage>1863</fpage>–<lpage>1867</lpage>.<pub-id pub-id-type="pmid">27075689</pub-id></mixed-citation>
</ref>
<ref id="ccr31361-bib-0006">
<label>6</label>
<mixed-citation id="ccr31361-cit-0006" publication-type="journal">
<string-name>
<surname>Gelsi‐Boyer</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Trouplin</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Adélaïde</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Bonansea</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Cervera</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Carbuccia</surname>
</string-name>, et al. <year>2009</year>
<article-title>Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia</article-title>. <source/>Br. J. Haematol.
<volume>145</volume>:<fpage>788</fpage>–<lpage>800</lpage>.<pub-id pub-id-type="pmid">19388938</pub-id></mixed-citation>
</ref>
<ref id="ccr31361-bib-0007">
<label>7</label>
<mixed-citation id="ccr31361-cit-0007" publication-type="journal">
<string-name>
<surname>Kaname</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Yanagi</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Chinen</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Makita</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Okamoto</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Maehara</surname>
</string-name>, et al. <year>2007</year>
<article-title>Mutations in CD96, a member of the immunoglobulin superfamily, cause a form of the C (Opitz trigonocephaly) syndrome</article-title>. <source/>Am. J. Hum. Genet.
<volume>81</volume>:<fpage>835</fpage>–<lpage>841</lpage>.<pub-id pub-id-type="pmid">17847009</pub-id></mixed-citation>
</ref>
<ref id="ccr31361-bib-0008">
<label>8</label>
<mixed-citation id="ccr31361-cit-0008" publication-type="journal">
<string-name>
<surname>Katoh</surname>, <given-names>M.</given-names>
</string-name>
<year>2013</year>
<article-title>Functional and cancer genomics of ASXL family members</article-title>. <source/>Br. J. Cancer
<volume>109</volume>:<fpage>299</fpage>–<lpage>306</lpage>.<pub-id pub-id-type="pmid">23736028</pub-id></mixed-citation>
</ref>
<ref id="ccr31361-bib-0009">
<label>9</label>
<mixed-citation id="ccr31361-cit-0009" publication-type="journal">
<string-name>
<surname>Kuechler</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>J. C.</given-names>
<surname>Czeschik</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Graf</surname>
</string-name>, <string-name>
<given-names>U.</given-names>
<surname>Grasshoff</surname>
</string-name>, <string-name>
<given-names>U.</given-names>
<surname>Hüffmeier</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Busa</surname>
</string-name>, et al. <year>2016</year>
<article-title>Bainbridge‐Ropers syndrome caused by loss‐of‐function variants in ASXL3: a recognizable condition</article-title>. <source/>Eur. J. Hum. Genet.
<volume>25</volume>:<fpage>183</fpage>–<lpage>191</lpage>.<pub-id pub-id-type="pmid">27901041</pub-id></mixed-citation>
</ref>
<ref id="ccr31361-bib-0010">
<label>10</label>
<mixed-citation id="ccr31361-cit-0010" publication-type="journal">
<string-name>
<surname>Millar</surname>, <given-names>J. K.</given-names>
</string-name>, <string-name>
<given-names>J. C.</given-names>
<surname>Wilson‐Annan</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Anderson</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Christie</surname>
</string-name>, <string-name>
<given-names>M. S.</given-names>
<surname>Taylor</surname>
</string-name>, <string-name>
<given-names>C. A.</given-names>
<surname>Semple</surname>
</string-name>, et al. <year>2000</year>
<article-title>Disruption of two novel genes by a translocation co‐segregating with schizophrenia</article-title>. <source/>Hum. Mol. Genet.
<volume>22</volume>:<fpage>1415</fpage>–<lpage>1423</lpage>.</mixed-citation>
</ref>
<ref id="ccr31361-bib-0011">
<label>11</label>
<mixed-citation id="ccr31361-cit-0011" publication-type="journal">
<string-name>
<surname>Nagasaki</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Yasuda</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Katsuoka</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Nariai</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Kojima</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Kawai</surname>
</string-name>, et al. <year>2015</year>
<article-title>Rare variant discovery by deep whole‐genome sequencing of 1,070 Japanese individuals</article-title>. <source/>Nat. Commun.
<volume>21</volume>(<issue>6</issue>):<fpage>8018</fpage>.</mixed-citation>
</ref>
<ref id="ccr31361-bib-0012">
<label>12</label>
<mixed-citation id="ccr31361-cit-0012" publication-type="journal">
<string-name>
<surname>Naritomi</surname>, <given-names>K.</given-names>
</string-name>
<year>1998</year>
<article-title>Application for an original computerized database (UR‐DBMS) for diagnosis of the malformation syndromes</article-title>. <source/>Cong. Anom.
<volume>38</volume>:<fpage>251</fpage>–<lpage>258</lpage>.</mixed-citation>
</ref>
<ref id="ccr31361-bib-0013">
<label>13</label>
<mixed-citation id="ccr31361-cit-0013" publication-type="journal">
<string-name>
<surname>Schumacher</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Laje</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Abou Jamra</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Becker</surname>
</string-name>, <string-name>
<given-names>T. W.</given-names>
<surname>Mühleisen</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Vasilescu</surname>
</string-name>, et al. <year>2009</year>
<article-title>The DISC locus and schizophrenia: evidence from an association study in a central European sample and from a meta‐analysis across different European populations</article-title>. <source/>Hum. Mol. Genet.
<volume>18</volume>:<fpage>2719</fpage>–<lpage>2727</lpage>.<pub-id pub-id-type="pmid">19414483</pub-id></mixed-citation>
</ref>
<ref id="ccr31361-bib-0014">
<label>14</label>
<mixed-citation id="ccr31361-cit-0014" publication-type="journal">
<string-name>
<surname>Shashi</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<given-names>L. D.</given-names>
<surname>Pena</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Kim</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Burton</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Hempel</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Schoch</surname>
</string-name>, et al. <year>2016</year>
<article-title>De novo truncating variants in ASXL2 are associated with a unique and recognizable clinical phenotype</article-title>. <source/>Am. J. Hum. Genet.
<volume>99</volume>:<fpage>991</fpage>–<lpage>999</lpage>.<pub-id pub-id-type="pmid">27693232</pub-id></mixed-citation>
</ref>
<ref id="ccr31361-bib-0015">
<label>15</label>
<mixed-citation id="ccr31361-cit-0015" publication-type="journal">
<string-name>
<surname>Song</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Feng</surname>
</string-name>, <string-name>
<given-names>L. L.</given-names>
<surname>Heston</surname>
</string-name>, <string-name>
<given-names>W. A.</given-names>
<surname>Scaringe</surname>
</string-name>, and <string-name>
<given-names>S. S.</given-names>
<surname>Sommer</surname>
</string-name>. <year>2008</year>
<article-title>Identification of high risk DISC1 structural variants with a 2% attributable risk for schizophrenia</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>367</volume>:<fpage>700</fpage>–<lpage>706</lpage>.<pub-id pub-id-type="pmid">18164685</pub-id></mixed-citation>
</ref>
<ref id="ccr31361-bib-0016">
<label>16</label>
<mixed-citation id="ccr31361-cit-0016" publication-type="journal">
<string-name>
<surname>Srivastava</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>K. C.</given-names>
<surname>Ritesh</surname>
</string-name>, <string-name>
<given-names>Y. C.</given-names>
<surname>Tsan</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Liao</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Su</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Cao</surname>
</string-name>, et al. <year>2016</year>
<article-title>De novo dominant ASXL3 mutations alter H2A deubiquitination and transcription in Bainbridge‐Ropers syndrome</article-title>. <source/>Hum. Mol. Genet.
<volume>25</volume>:<fpage>597</fpage>–<lpage>608</lpage>.<pub-id pub-id-type="pmid">26647312</pub-id></mixed-citation>
</ref>
<ref id="ccr31361-bib-0017">
<label>17</label>
<mixed-citation id="ccr31361-cit-0017" publication-type="journal">
<string-name>
<surname>Zielinski</surname>, <given-names>B. A.</given-names>
</string-name>, <string-name>
<given-names>M. B.</given-names>
<surname>Prigge</surname>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Nielsen</surname>
</string-name>, <string-name>
<given-names>A. L.</given-names>
<surname>Froehlich</surname>
</string-name>, <string-name>
<given-names>T. J.</given-names>
<surname>Abildskov</surname>
</string-name>, <string-name>
<given-names>J. S.</given-names>
<surname>Anderson</surname>
</string-name>, et al. <year>2014</year>
<article-title>Longitudinal changes in cortical thickness in autism and typical development</article-title>. <source/>Brain
<volume>137</volume>:<fpage>1799</fpage>–<lpage>1812</lpage>.<pub-id pub-id-type="pmid">24755274</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>